Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Working Groups Hot Topics

Image Added


PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global.


Image Added


Open Source – Regulatory Acceptance of Open-Source Submissions
PHUSE/FDA CSS 2024Image Removed

Registration for the

PHUSE/FDA CSS 2024

Open Source Open Forum is open!

Come and be a part of the PHUSE/FDA Computational Science Symposium 2024 (CSS) taking place 3–5 June in Silver Spring, MD. Share your insights, discoveries and solutions with the PHUSE Community, who are eager to learn and collaborate. 

Status
colourBlue
titleRegister Here

Community Forums

Image Removed

The Open Source Technology in Clinical Data Analysis (OSTCDA) project is hosting their fourth Open Forum: Regulatory Acceptance of Open-Source Submissions, they will be addressing the following questions:

  • Will the FDA accept data and analyses generated with solutions developed and available as open source?
  • Will other regulatory agencies accept data and analyses generated with solutions developed and available as open source?

Come and be a part of our next virtual Open Forum on 12 July at 15:00(BST) 10:00

TheEmerging Trends & Technologies Working Group is hosting a Community Forum where speaker Dr. Junshui Ma, Merck who will be using his experience in pharmaceutical R&D to speak on the Innovations in Healthcare in the Age of Generative AI and will illustrate how generative AI is empowering every innovative mind. This forum will be taking place over Zoom on 17 April 14:00–15:30 (BST) / 09:00–10:30

(EDT).

Status
colourBlue
titleRegister Here


Understanding the Complete Journey of RWD, from Data Source to Final Analysis 

Registration for the RWE Community Forum is open!

The Real World Evidence Working Group

will be

is hosting

a

their third Community Forum

called Meet the Real-World Data Provider.

of the year! This forum will

hear from three speakers Michèle Arnoe, IQVIA, Jeffrey Brown, TriNetX andBenjamin Forred, Sanford Research who will cover a range of topics related to data provision, including the challenges associated with delivering data to the end user and the various ways in which the data provider can assist. This forum will take place on 

looking at 'Understanding the Complete Journey of RWD, from Data Source to Final Analysis'. As an industry, we are continuously accumulating experiences in working with real-world data (RWD) sources that collectively yield benefits – from enhanced generalisability of findings to facilitating faster approval timelines. However, these efforts are not without their challenges.

Come and be a part of our next virtual Community Forum on 11 July at 14:00(BST) 9

18 April 14:00–15:00 (BST) 09:00–10

:00(EDT).

Status
colourBlue
titleRegister Here

Volunteer Opportunities


Image Added


Image Removed

The

The Dataset-JSON as Alternative Transport Format for Regulatory Submissions project within the Optimizing the Use of Data Standards Working Group

is looking for a new Working Group Lead to join their team. Over the last decade, the development and adoption of data standards have shown significant promise in improving the efficient delivery of data to support drug product and device submissions as well as the review process. However, there have also been gaps, issues and challenges in the interpretation and use of data standards.

The goal of this Working Group is to work together to identify and close those particular gaps that impede industry and the FDA from making the most efficient use of data standards. Click here to see a list of current projects within this Working Group.

Learn more about the roles and the responsibilities of a Working Group Lead and apply by emailing workinggroups@phuse.global. Closing date 5 April.

The Nonclinical Topics Working Group has initiated a new Project called ‘Supporting the Use of SEND for the Implementation of Virtual Control Groups which is now calling for volunteers! This project will leverage the deep SEND knowledge and experience of the PHUSE Nonclinical Topics Working Group by initially focusing on the development of best practices with respect to population of SEND datasets with data from virtual control animals. This project will be working alongside the Nonclinical Scripts project also within the Nonclinical Topics Working Group and provide an open venue for the socialisation and hosting of open-source software solutions related to selection procedures and database infrastructure. If you are interested in joining, please contact workinggroups@phuse.global. Closing date 13 April.

, has published a new white paper. A pilot was executed to test the feasibility of using Dataset-JSON as a transport format for study data submitted with regulatory applications. The goal was to demonstrate that Dataset-JSON can serve as a transport file for study data without loss of data and no significant impact to business operations.  

CDISC Dataset-JSON is a modern dataset format designed for data exchange. Many software applications already import and export JSON and in the longer term more significant benefits will emerge as the constraints imposed by XPT are removed. 

Overall, the findings were consistent across industry and the FDA supporting the use of Dataset-JSON as an alternative transport format for XPT v5.  There were several key findings from the pilot and the solutions to these will be implemented in Dataset-JSON v1.1 (due end of 2024). 

PHUSE and CDISC will continue to collaborate with the FDA/PMDA to discuss next steps for regulatory support. FDA/CDER/CBER testing strongly suggests that analytical tools used for regulatory review are updated to take advantage of the metadata and flexibility provided by the Dataset-JSON format. 


The SEND Industry Feedback Surveyproject within the Nonclinical Topics Working Group, has published the 2024 SEND Survey Results. The survey was presented at the PHUSE/FDA Computational Science Symposium (CSS) 2024 and covered topics such as Manual Edits, Implementing SEND, Harmonisation and Next Steps.


The Adverse Event Collection Recommendations project within the Safety Analytics Working Group, has published a new white paper The Adverse Event Collection Recommendations. This white paper provides recommendations for adverse event (AE) collection and associated instructions for Phase II to III clinical trials, building on standardisation efforts by Clinical Data Interchange Standards Consortium (CDISC) and PHUSE. The primary intent is to reduce the variation in AE collection and instructions to improve the site experience and the quality of the data.


The Quality and Reusability of Real World Data project within the Real World Evidence Working Group, has published two new Blogs! The 'Understanding the Data Quality Issues in Real-World Data Through Real-World Examples', blog takes a closer look at the experiences shared within the dedicated Working Group in exploring the types of data quality hurdles encountered when using Real-World Data (RWD).The 'Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products' blog explores the use of Real-World Evidence (RWE) as a powerful tool for informing regulatory decisions and advancing medical innovation.


The Educate the General Population on Data Privacy and Data Sharing project, within the Data Transparency Working Group has published video 2 of their series. The 'What Will I Receive and When Will I Receive It?The video covers topics such as the concept of consent to participate in a clinical trial, an overview of trial design and treatment procedures to develop a strong foundational understanding of clinical trials. To view the full series of videos created by this team, visit the PHUSE website


Image Added


The Enhanced Risk-based Quality Management (RBQM) Approaches for First-in-Human and/or Small Clinical Trialsa new project within the Risk Based Quality ManagementWorking Group, is now calling for volunteers. This project aims to to discuss and focus on a robust strategy/process and best practices for:

  • Identifying critical items
  • Risk Based data review approaches
  • Risk Based Monitoring approach strategy (tSDV/tSDR)
  • Usage of analytical tools and methods for data review & central monitoring, including limitations on (statistical) methodologies
  • Identification of thresholds or equivalent on limited patient data
  • Targeted medical review
  • Strategy to adequately anticipate on highly dynamic data
  • Establish links with the other work streams on FIH/small studies focus

If you would like to volunteer or learn more about this project, email workinggroups@phuse.global. Closing date: 5 July

The Data Visualisation & Open Source Technology Working Group has a new project, Demonstrating Real-World Impact of Modernization of Statistical Analytics (MSA) Framework.  This project aims to extend the MSA framework by creating a reference architecture that takes into account real-world scenarios and design solutions to remediate them, ultimately providing a practical guide to building an end-to-end validated environment for regulated work. Companies seeking to build an open-source programming environment for regulatory reporting can leverage the MSA framework for guidance. However, since the framework is designed to be both flexible and extensible, implementing it may prove challenging for companies, resulting in situations where risks are not sufficiently mitigated. While the original MSA paper provided conceptual guidance, the PHUSE handover of the project will seek to provide an overview of practical implementations of the framework being applied.

This project is calling for volunteers, to join contact  workinggroups@phuse.global by 26 April.

The Safety Analytics Working Group is looking for a new Working Group Lead to join their team. This Working Group is a cross-disciplinary collaboration working to improve the content and implementation of clinical trial safety analyses for medical research, leading to better data interpretations and increased efficiency in the clinical drug development and review processes.

Click here to see a list of current projects within this Working Group.

Learn more about the roles and the responsibilities of a Working Group Lead and apply by emailing workinggroups@phuse.global. Closing date 26 April.

Multiple projects within Working Groups are open to join. PHUSE welcomes new members who can apply their knowledge to bring fresh ideas and contribute to the ongoing work of PHUSE projects. For more information, click here, read the Welcome Pack or email workinggroups@phuse.global

PHUSE Communications 

Image Removed


Image Added


Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group.

Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE.

PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. 

BIMO FAQ Forum Global SurveyDo you have a question relating to Bioresearch Monitoring (BIMO)? The Bioresearch Monitoring (BIMO) Frequently Asked Questions Forum project within the Optimizing the Use of Data Standards Working Group are here to help. You can find all previous BIMO questions and answers publishedhere

Instructions for submitting your questions via the BIMO FAQ Survey:

Download the file named PHUSE BIMO FAQ Forum Project _Global Survey for collecting your questions.xlsxto add your questions to the BIMO FAQ Survey.
  • Complete the file with your questions as per the instructions in the ‘Survey Instructions’ tab.
  • Save and submit to the PHUSE BIMO FAQ Forum Project Team via email at workinggroups@phuse.global by 31 March.
  • We look forward to receiving your BIMO questions!

    New Project Idea? 


    Image Added


    Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements: 

    • The projects must address significant research issues relevant to Computational Science
    • The project must not attempt to address FDA policy issues
    • There must be at least one Project Lead personally involved in planning and carrying out the project

    New projects can be submitted anytime during the year, click here to submit.